CIK 0001799191
- Accelerated filer
- Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN STLNW DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843562323
- Phone
- +1 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Common stock Nasdaq
- DFPH Common stock OTC
- 4 Other disposition Chief Financial Officer disposed of 1,314 shares (other)
- 4 Other disposition Chief Medical Officer disposed of 3,420 shares (other)
- 4 Open-market buy 10% owner bought 398,985 shares at an average $3.07 ($1,225,101)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4/A Other disposition Chief Financial Officer disposed of 244 shares (other)
- 4 Open-market sale Chief Financial Officer sold 247 shares at $3.56 ($879)
- 4 Open-market sale Director sold 13,333 shares at $3.77 ($50,291)
- 4 Insider Changes in Ownership
- 4 Grant or award Director acquired 108,024 shares (grant or award)
- 4 Grant or award Director acquired 91,049 shares (grant or award)
- 4 Grant or award Director acquired 83,333 shares (grant or award)
- 4 Grant or award Director acquired 84,877 shares (grant or award)
- 4 Grant or award Director acquired 81,790 shares (grant or award)
- 4 Grant or award Director acquired 74,074 shares (grant or award)
- 4 Open-market sale Director sold 50,000 shares at $4.00 ($200,000)
- 4 Other acquisition Director acquired 141,149 shares (other)
- 4 Other disposition Director disposed of 3,090,892 shares (other)
- 4 Grant or award Chief Executive Officer acquired 6,464 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 2,086 shares (grant or award)
Page 3 of 14 · 269 filings